Medical Photonics platform for Ageing (MEDPHOTAGE): Photonic, non-invasive, point-of-care platform for the assessment of cerebrovascular risk associated with aging (Q3178201): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Aging is the main risk factor for cerebrovascular diseases (such as stroke), cognition disorders and mobility. As the population ages, these pathologies associated with ageing entail enormous socio-economic costs. To ensure healthy ageing, preventive care and personalised interventions based on quantitative risk stratification are crucial. Our hypothesis is that microvascular lesions and alterations in cerebrovascular reactivity and self-regulat...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Medical Photonics platform for Ageing (MEDPHOTAGE): Photonic, non-invasive, point-of-care platform for the assessment of cerebrovascular risk associated with aging | |||
Revision as of 18:55, 12 October 2021
Project Q3178201 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Medical Photonics platform for Ageing (MEDPHOTAGE): Photonic, non-invasive, point-of-care platform for the assessment of cerebrovascular risk associated with aging |
Project Q3178201 in Spain |
Statements
30,250.0 Euro
0 references
60,500.0 Euro
0 references
50.0 percent
0 references
1 January 2017
0 references
31 March 2019
0 references
INSTITUTO DE CIENCIAS FOTONICAS
0 references
41°17'9.96"N, 1°58'56.71"E
0 references
08056
0 references
El envejecimiento es el principal factor de riesgo para enfermedades cerebrovasculares (como el ictus), trastornos de cognición y movilidad. A medida que la población envejece, estas patologías asociadas con el envejecimiento suponen costes socio-económicos enormes. Para asegurar un envejecimiento saludable, el cuidado preventivo y las intervenciones personalizadas basadas en la estratificación del riesgo cuantitativo son cruciales. Nuestra hipótesis es que las lesiones microvasculares y alteraciones en la reactividad cerebrovascular y la autorregulación juegan un papel crítico en el aumento del riesgo de enfermedades cerebrovasculares, trastornos de la cognición y de la movilidad. Nuestra hipótesis secundaria es que tener un sistema de monitorización sencillo de usar y disponible para todo el mundo y protocolos de pruebas asociados permitirán la detección temprana de alteraciones sutiles en estos factores, lo cual permitirá, intervenciones personalizadas. En este proyecto coordinado, nos centramos en el desarrollo y utilización inicial de una plataforma innovadora que mide a nivel cerebral y muscular la hemodinámica microvascular local y el metabolismo del oxígeno. Esta plataforma se basa en una combinación única de tecnologías (espectroscopia de infrarrojo cercano y espectroscopia de correlación de luz difusa) y de conocimiento en distintas materias (óptica médica, neurología y geriatría). Forma un conjunto con sus objetivos (un área de aplicación innovadora con un impacto crucial). Trabajaremos conjuntamente con la empresa Hemophotonics para explotar los allazgos siguiendo las conclusiones del proyecto. Desarrollaremos la plataforma (ICFO, SP1) guiada por los expertos usuarios finales (Pere Virgili, SP2) para ser una plataforma tipo point-of-care , no invasiva, que será validada, y cuya viabilidad será demostrada sobre un grupo seleccionado de sujetos. Esperamos que los resultados conduzcan a un enorme impacto socio-económico en envejecimiento saludable. (Spanish)
0 references
Aging is the main risk factor for cerebrovascular diseases (such as stroke), cognition disorders and mobility. As the population ages, these pathologies associated with ageing entail enormous socio-economic costs. To ensure healthy ageing, preventive care and personalised interventions based on quantitative risk stratification are crucial. Our hypothesis is that microvascular lesions and alterations in cerebrovascular reactivity and self-regulation play a critical role in increasing the risk of cerebrovascular diseases, cognition and mobility disorders. Our secondary hypothesis is that having an easy-to-use monitoring system available to everyone and associated testing protocols will allow the early detection of subtle alterations in these factors, which will allow personalised interventions. In this coordinated project, we focus on the development and initial use of an innovative platform that measures at the brain and muscle level local microvascular hemodynamics and oxygen metabolism. This platform is based on a unique combination of technologies (near infrared spectroscopy and diffuse light correlation spectroscopy) and knowledge in different subjects (medical optics, neurology and geriatrics). It forms a set with its objectives (an innovative area of application with a crucial impact). We will work together with the company Hemophotonics to exploit the raids following the conclusions of the project. We will develop the platform (ICFO, SP1) guided by the expert end-users (Pere Virgili, SP2) to be a non-invasive point-of-care platform that will be validated and whose viability will be demonstrated on a selected group of subjects. We hope the results will lead to a huge socio-economic impact on healthy aging. (English)
12 October 2021
0 references
Castelldefels
0 references
Identifiers
DTS16_00087
0 references